We recently published a list of 10 Must-Watch AI Stocks on Investors’ Radar. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other must-watch AI stocks on investors’ radar.
With everyone competing towards supremacy in artificial intelligence, the latest country to intensify its efforts has been Britain. As reported by Reuters, British Prime Minister Keir Starmer said on Monday, January 13th, that he wanted to make the UK an artificial intelligence “superpower”. To reach this goal, the Prime Minister has promised to take a pro-innovation approach to regulation, make public data available to researchers, and create zones for data centers.
Starmer plans to make artificial intelligence a key part of his strategy to boost the economy. According to the government, the technology could improve productivity by 1.5% a year, translating to an extra 47 billion pounds ($57 billion) annually over a decade.
“Britain will be one of the great AI superpowers. We’re going to make the breakthroughs, we’re going to create the wealth, and we’re going to make AI work for everyone in our country”.
Another country that has been actively striving towards reaching supremacy when it comes to AI has been the US. In its latest efforts, the US government is moving to restrict artificial intelligence chip and technology exports further. Dozens of countries will be facing new restrictions on the export of advanced computer chips and other artificial intelligence (AI) technology. According to officials, the new rules are intended to make sure that “the world’s AI runs on American rails” and keep it out of the hands of “malicious actors” who could use it to threaten the United States.
Even though the US government may think it’s heading in the right direction, many top tech companies don’t necessarily agree.
“In the wrong hands, powerful AI systems have the potential to exacerbate significant national security risks, including by enabling the development of weapons of mass destruction, supporting powerful offensive cyber operations, and aiding human rights abuses, such as mass surveillance”.
Chipmaker Nvidia is also against these restrictions and will be the most impacted by the plan. According to the chipmaker, if the restrictions are implemented, they would not “mitigate any threat” but only “weaken America’s global competitiveness” and undermine its innovation.
“By attempting to rig market outcomes and stifle competition—the lifeblood of innovation—the Biden Administration’s new rule threatens to squander America’s hard-won technological advantage”.
For this article, we selected AI stocks by going through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
Tempus AI Inc (TEM): AI-Driven Healthcare Revolution
Tempus AI, Inc (NASDAQ:TEM) is a healthcare technology company that provides AI-enabled precision medicine solutions. On January 14, the company unveiled a suite of new, transformative capabilities available in Tempus One, the company’s generative AI assistant. Tempus One, the company’s generative AI-enabled clinical assistant, is designed to revolutionize patient care and precision medicine by offering data-driven decision support in the clinic as well as evolving research to bring new drugs to market. Using Tempus’ proprietary Large Language Model (LLM) Agent Infrastructure (Agent Builder), Tempus One processes unstructured healthcare data for improving clinical research and care. Tempus One’s latest iteration includes four breakthrough generative AI-powered capabilities that leverage LLMs to derive insights from the said unstructured data.
“When we launched Tempus One a few years ago, our hope was that it would grow and scale in intelligence for the benefit of clinicians, researchers, and patients. We’ve been blown away by the evolution of this product which is designed to continually evolve so that we can easily deploy new generative AI solutions to our customers to address their evolving needs. For example, LLMs now give us the opportunity to derive new insights from unstructured data, which has some of the richest patient data and until now, was extremely difficult to access at scale”.
Overall, TEM ranks 6th on our list of must-watch AI stocks on investors’ radar. While we acknowledge the potential of TEM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TEM but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
